Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment/Experiment 8

From BugSigDB


Reviewed Marked as Reviewed by Svetlana up on 2024-7-23

Curated date: 2024/04/21

Curator: Scholastica

Revision editor(s): Scholastica

Subjects

Location of subjects
France
Italy
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Breast cancer breast cancer,breast tumor,cancer of breast,malignant breast neoplasm,malignant breast tumor,malignant neoplasm of breast,malignant neoplasm of the breast,malignant tumor of breast,malignant tumor of the breast,mammary cancer,mammary neoplasm,mammary tumor,primary breast cancer,Breast cancer
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy volunteers
Group 1 name Corresponds to the case (exposed) group for case-control studies
Breast cancer patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Breast cancer patients enrolled in the CANTO study
Group 0 sample size Number of subjects in the control (unexposed) group
336
Group 1 sample size Number of subjects in the case (exposed) group
76
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
None

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Ion Torrent

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2


Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2024-7-23

Curated date: 2024/04/22

Curator: Scholastica

Revision editor(s): Scholastica

Source: Fig. 2A

Description: Metagenomics analyses of stool samples from breast cancer patients compared with healthy volunteers (HV) using LEfSe method

Abundance in Group 1: increased abundance in Breast cancer patients

NCBI Quality ControlLinks
Alistipes communis
Alistipes indistinctus
Alistipes shahii
Bacteroides finegoldii
Bacteroides nordii
Bilophila wadsworthia
Clostridiales bacterium 1_7_47FAA
Clostridium sp. KLE 1755
Dhillonvirus JL1
Enterocloster asparagiformis
Enterocloster bolteae
Enterocloster clostridioformis
Escherichia phage phAPEC8
Lactococcus phage 936
Phocaeicola barnesiae
Ruminococcaceae bacterium D16
unclassified Bilophila
unclassified Ceduovirus
unclassified Megasphaera
unclassified Mitsuokella
Anaerostipes sp. 3_2_56FAAAnaerostipes sp. 3_2_56FAA
Bacteroides ovatus
Odoribacter splanchnicus
unclassified Oscillibacter
Roseburia intestinalis
unclassified Alistipes
Parabacteroides merdae
Klebsiella pneumoniae
Lachnospira eligens
Barnesiella intestinihominis
Faecalibacterium prausnitzii
Parabacteroides distasonis
Bacteroides fragilis
Sodalis phage SO-1
Bacteroides thetaiotaomicron
Alistipes putredinis
Segatella copri
Bacteroides uniformis

Revision editor(s): Scholastica

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2024-7-23

Curated date: 2024/04/22

Curator: Scholastica

Revision editor(s): Scholastica

Source: Fig. 2A

Description: Metagenomics analyses of stool samples from breast cancer patients compared with healthy volunteers (HV) using LEfSe method

Abundance in Group 1: decreased abundance in Breast cancer patients

NCBI Quality ControlLinks
Bifidobacterium adolescentis
Agathobacter rectalis
Ruminococcus sp. 5_1_39BFAA
Bifidobacterium longum
Collinsella aerofaciens
Anaerobutyricum hallii
Methanobrevibacter smithii
Eshraghiella crossota
[Ruminococcus] torques
Dorea longicatena
Bacteroides stercoris
Leyella stercorea
Blautia obeum
Holdemanella biformis
Coprococcus comes
Dorea formicigenerans
[Eubacterium] siraeum
Porphyromonas bennonis
Phascolarctobacterium succinatutens
Finegoldia magna
Clostridium sp. L2-50
Catenibacterium mitsuokai
Treponema succinifaciens
Bifidobacterium pseudocatenulatum
Bifidobacterium catenulatum
Coprococcus catus
Hoylesella buccalis
Coprococcus eutactus
Bifidobacterium angulatum
Streptococcus salivarius
Peptoniphilus lacrimalis
Bacteroides intestinalis
Streptococcus thermophilus
Ligilactobacillus ruminis
Eubacterium ramulus
unclassified Peptostreptococcaceae
Ruminococcus champanellensis
Streptococcus anginosus
Anaerococcus vaginalis
unclassified Eggerthella
Enterobacter cloacae
unclassified Methanobrevibacter
Enterococcus faecalis
Streptococcus infantarius
Escherichia sp. TW09276
Porphyromonas somerae
Oscillibacter sp. KLE 1745
Peptoniphilus harei
Hungatella hathewayi
Anaerococcus obesiensis
Gordonibacter pamelaeae
Porphyromonas uenonis

Revision editor(s): Scholastica